ArticleBMC cancer2026

Downregulation of THRB drives immune microenvironment suppression and poor outcomes, acting as a dual biomarker for clear cell renal cell carcinoma.

Suzhen Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.